Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biocollection in Patients With Myelodysplastic Syndrome (P-MDS)

NCT04869683 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT04869683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04869683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biocollection in Patients With Myelodysplastic Syndrome (P-MDS)
Lead sponsor
University Hospital, Brest
Phase
Not applicable
Overall status
Recruiting
Start date
October 19, 2022
Completion date
October 19, 2032
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia with multilineage dysplasia, chromosome abnormality, myelodysplastic anemia, myelodysplastic syndrome with isolated del(5q), myelodysplastic syndrome with ring sideroblasts, myelodysplastic syndromes